| NDC Code | 70934-902-30 |
|---|
| Package Description | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-902-30) |
|---|
| Product NDC | 70934-902 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Verapamil Hydrochloride |
|---|
| Non-Proprietary Name | Verapamil Hydrochloride |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20210928 |
|---|
| End Marketing Date | 20230430 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA090700 |
|---|
| Manufacturer | Denton Pharma, Inc. DBA Northwind Pharmaceuticals |
|---|
| Substance Name | VERAPAMIL HYDROCHLORIDE |
|---|
| Strength | 180 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
|---|